Preventative health and longevity company Fountain Life has landed $15 million in funding from Eos Venture Partners and Newcross Healthcare.
WHO: Fountain Life was founded in 2020 by life and business strategist Tony Robbins; author and entrepreneur Peter Diamandis; and surgeon, biomedical scientist, and entrepreneur Dr. Bob Hariri. Launched as a health insurance business, Fountain Life has dedicated centers in Florida, New York, Texas, and India. Members can also receive its services via telehealth where the law permits. Fountain Life brings together the world's most renowned scientists and physicians to boost longevity and performance, putting health back in healthcare. Fountain Life does this by using cutting-edge artificial intelligence to collect data and gain insights into the human body that have never been possible before. Fountain Life's data-driven approach enables finding illnesses, including cancer and cardiac, metabolic, and neurodegenerative disease, early before they can cause harm.
WHY: The new investment will help further advance future US and global expansion, bringing unique healthcare screening and engagement capabilities to more people.
IN THEIR OWN WORDS: "Detecting asymptomatic disease is challenging because the human body is amazing at masking symptoms, but diagnostic technologies have come a long way. The ability to screen for structural abnormalities and other key indicators of developing disease exists today, but we must change the healthcare delivery model to truly realize the benefits of early disease detection," said Bill Kapp, Fountain Life CEO and co-founder. "The best way to avoid or mitigate long term issues is to look for them early—waiting until conditions manifest themselves and require costly treatment is suboptimal and can lead to reduced longevity and quality of life. We are humbled by the commitment by Eos Venture Partners and Newcross Healthcare to support this transformation."
"We are delighted to announce our investment and partnership with Fountain Life, a unique business combining the latest in precision diagnostics with an insurance business to democratize access to leading medical technology," said Eos partner Sam Evans. "We look forward to working with the team to support their product and geographic expansion plans."
"We are very pleased to become a strategic investor in Fountain Life. The future transformation of care will be greatly enhanced by a focus on wellness and preventative diagnostics as well as advancements in treatment and care at home enabled by technology and a highly skilled healthcare workforce," said Stephen Pattrick, CEO and co-founder of Newcross Healthcare.
DETAILS:
